Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological DMARDs: Results at 60 Weeks Genovese, M., Combe, B., Hall, S., Rubbert-Roth, A., Zhong, S., Meerwein, S., Pangan, A., Fleischmann, R. WILEY. 2019

View details for Web of Science ID 000507466900519